Related Experiment Video
Updated: Jul 14, 2026
09:42
Comprehensive Analysis of Drug Response using the FLICK Assay
Published on: June 6, 2025
Analysis of cell death inducing compounds
Jeppe S Spicker1, Henrik Toft Pedersen, Henrik Bjørn Nielsen
1Center for Biological Sequence Analysis, BioCentrum-DTU, Technical University of Denmark, Kemitorvet, Building 208, 2800, Lyngby, Denmark. hbjorn@cbs.dtu.dk
Archives of Toxicology
|May 16, 2007
Summary
This study identifies novel gene biomarkers for early detection of liver toxicity in drug development. Ornithine aminotransferase (OAT) showed exceptional promise, correctly classifying all tested samples as toxic or non-toxic.
Area of Science:
- Toxicology
- Genomics
- Drug Development
Background:
- Early detection of drug-induced liver toxicity is crucial for improving drug development success rates.
- Gene expression profiling offers a potential avenue for identifying predictive toxicity biomarkers.
Purpose of the Study:
- To identify and validate gene expression biomarkers for predicting liver toxicity.
- To assess the performance of identified biomarkers in classifying toxic versus non-toxic samples.
Main Methods:
- Gene expression levels were measured using Affymetrix GeneChips in rat liver tissue after compound administration.
- Quantitative RT-PCR was employed for validation of selected gene transcripts.
- Microarray and RT-PCR data were used to classify samples based on toxicity.
Main Results:
- Three candidate gene transcripts (GCKR, OAT, Cyp2C29) were identified with predictive performance for liver toxicity.
- A classification rate of 55 out of 57 samples was achieved using the three genes.
- Ornithine aminotransferase (OAT) alone demonstrated 100% accuracy in classifying toxic and non-toxic samples.
Conclusions:
- GCKR, OAT, and Cyp2C29 are promising biomarkers for early liver toxicity detection.
- OAT is a novel, highly effective biomarker for hepatotoxicity, warranting further investigation.
- These biomarkers could significantly enhance the safety assessment in drug development.
Related Concept Videos
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:11Cellular Injury IlI: Cellular Death
Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:16Necrosis
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...